MedPath

Dexamethasone for Pain After Shoulder Surgery

Phase 4
Completed
Conditions
Shoulder Impingement Syndrome
Arthritis
Interventions
Registration Number
NCT01414569
Lead Sponsor
University of Aarhus
Brief Summary

The purpose of this study is to determine if a dose of 40 mg dexamethasone is more effective as pain treatment than the currently used dose of 8 mg after arthroscopic shoulder surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
97
Inclusion Criteria
  • Arthroscopic subacromial decompression and/or acromioclavicular resection
  • General anaesthesia
  • Daysurgery, Horsens Hospital
Read More
Exclusion Criteria
  • Incompetent
  • Pregnant
  • Age under 18 or over 90 years
  • Allergy toward dexamethasone
  • Diabetes
  • Active gastric ulcer
  • Untreated hypertension
  • Glaucoma
  • Daily use of glucocorticoids or strong opioids
  • Daily use of analgesics for unrelated illness
  • Myasthenia gravis
  • Mitochondrial disorders
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
8 mg dexamethasoneDexamethasone-
Placebo, salineDexamethasone-
40 mg dexamethasoneDexamethasone-
Primary Outcome Measures
NameTimeMethod
Pain score by numeric rating scaleAt 8 hours postoperatively
Secondary Outcome Measures
NameTimeMethod
Use of analgesicsDuring hospital stay, about 4 hours

Need for supplemental analgesic medication during stay in recovery on the day of operation, until discharge.

Pain score by numeric rating scaleAt about 8 a.m. on the first postoperative day

On the morning of the first postoperative day, the self-evaluated level of pain as assessed by numeric rating scale.

Trial Locations

Locations (1)

Horsens Hospital

🇩🇰

Horsens, Denmark

© Copyright 2025. All Rights Reserved by MedPath